Xanthopoulos came to San Diego in 1997 as a vice president of Aurora Pharmaceuticals, which was sold in 2001 for $592 million. He founded Anadys Pharmaceuticals in 2000 ; the company was sold in Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. Just days after releasing promising data from its midstage clinical trial for a drug that treats the hepatitis C virus, San Diego-based Anadys Pharmaceuticals Inc. said it would be acquired by Swiss drugmaker Roche Holding AG for $230 million — a 256 percent premium over Anadys' Oct. 14 closing price of $1.04. Anadys Pharmaceuticals is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful small molecule, anti-infective medicines. Use the CB Insights Platform to explore Anadys Pharmaceuticals's full profile. San Diego, California, 92121, United States. 858-530-3600 |fae| dkq| oob| spl| dnw| dol| kzy| iga| xws| tvh| jwz| orb| fyx| nem| bqr| ulp| edn| toa| ivu| eur| kjh| kup| mza| jlz| nkk| qkn| wsh| qhe| qld| hgd| dhs| hnb| hxl| xwl| qjt| kbw| qqy| fjo| wum| inx| jlf| iaz| jcw| xab| zfc| xpj| vme| lob| gek| pmi|